Literature DB >> 2854280

The Salmonella wien virulence plasmid pZM3 carries Tn1935, a multiresistance transposon containing a composite IS1936-kanamycin resistance element.

B Colonna1, M Bernardini, G Micheli, F Maimone, M Nicoletti, M Casalino.   

Abstract

Tn1935, a 23.5-kb transposon mediating resistance to ampicillin, kanamycin, mercury, spectinomycin, and sulfonamide was isolated from pZM3, an IncFIme virulence plasmid from Salmonella wien. Tn1935 possesses the entire sequence of Tn21 and contains two additional DNA segments of 0.95 and 2.7 kb carrying the ampicillin and kanamycin resistance genes, respectively. The latter is part of a composite element since it is flanked by two IS15-like insertion sequences (IS1936) in direct orientation. IS1936 is about 800 bp long and is closely related to IS15 delta, IS26, IS46, IS140, and IS176. Functional analysis of IS1936-mediated cointegrates shows that both insertion sequences are active and able to form cointegrates at the same frequency. Resolution of the cointegrates requires the presence of the host Rec system. The presence of the composite IS1936-element within Tn1935 supports the hypothesis that multidrug resistance transposons evolved by insertion of antibiotic determinants which are themselves transposable.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2854280     DOI: 10.1016/0147-619x(88)90028-5

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  14 in total

1.  Multiple-antibiotic resistance mediated by structurally related IncL/M plasmids carrying an extended-spectrum beta-lactamase gene and a class 1 integron.

Authors:  L Villa; C Pezzella; F Tosini; P Visca; A Petrucca; A Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 2.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

3.  In34, a complex In5 family class 1 integron containing orf513 and dfrA10.

Authors:  Sally R Partridge; Ruth M Hall
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

4.  Antibiotic resistance conferred by a conjugative plasmid and a class I integron in Vibrio cholerae O1 El Tor strains isolated in Albania and Italy.

Authors:  V Falbo; A Carattoli; F Tosini; C Pezzella; A M Dionisi; I Luzzi
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

Review 5.  Insertion sequences.

Authors:  J Mahillon; M Chandler
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

6.  An overview of current Italian studies on bacterial pathogenesis.

Authors:  G Falcone
Journal:  World J Microbiol Biotechnol       Date:  1992-12       Impact factor: 3.312

7.  Expanding drug resistance through integron acquisition by IncFI plasmids of Salmonella enterica Typhimurium.

Authors:  A Carattoli; L Villa; C Pezzella; E Bordi; P Visca
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

8.  Class 1 integron-borne multiple-antibiotic resistance carried by IncFI and IncL/M plasmids in Salmonella enterica serotype typhimurium.

Authors:  F Tosini; P Visca; I Luzzi; A M Dionisi; C Pezzella; A Petrucca; A Carattoli
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

9.  Organization of aerobactin, hemolysin, and antibacterial resistance genes in lactose-negative Escherichia coli strains of serotype O4 isolated from children with diarrhea.

Authors:  B Colonna; L Ranucci; P A Fradiani; M Casalino; A Calconi; M Nicoletti
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

10.  Characterization of In0 of Pseudomonas aeruginosa plasmid pVS1, an ancestor of integrons of multiresistance plasmids and transposons of gram-negative bacteria.

Authors:  L Bissonnette; P H Roy
Journal:  J Bacteriol       Date:  1992-02       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.